The Use of ADSCs as a Treatment for Chronic Stroke

Author:

Chan Tzu-Min12,Harn Horng-Jyh34,Lin Hui-Ping5,Chiu Shao-Chih16,Lin Po-Cheng7,Wang Hsin-I7,Ho Li-Ing8,Chuu Chih-Pin5,Chiou Tzyy-Wen9,Hsieh An-Cheng1,Chen Yu-Wen1,Ho Wen-Yu1011,Lin Shinn-Zong161213

Affiliation:

1. Center for Neuropsychiatry, China Medical University Hospital, Taichung, Taiwan

2. Everfront Biotech Inc., New Taipei City, Taiwan

3. Department of Medicine, China Medical University, Taichung, Taiwan

4. Department of Pathology, China Medical University Hospital, Taichung, Taiwan

5. Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan

6. Graduate Institute of Immunology, China Medical University, Taichung, Taiwan

7. GwoXi Stem Cell Applied Technology, Hsinchu, Taiwan

8. Department of Respiratory Therapy, Taipei Veterans General Hospital, Taipei, Taiwan

9. Department of Life Science and Graduate Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan

10. Department of Laboratory Medicine, China Medical University Beigang Hospital, Yunlin, Taiwan

11. Departmentof Medical Technology, Nursing and Management, Jen-Teh Junior College of Medicine, Taiwan

12. Department of Neurosurgery, China Medical University Beigang Hospital, Yunlin, Taiwan

13. Department of Neurosurgery, Tainan Municipal An-Nan Hospital, China Medical University, Tainan, Taiwan

Abstract

Stroke is one of the disorders for which clinically effective therapeutic modalities are most needed, and numerous ways have been explored to attempt to investigate their feasibilities. However, ischemic- or hemorrhagicinduced inflammatory neuron death causes irreversible injuries and infarction regions, and there are currently no truly effective drugs available as therapy. It is therefore urgent to be able to provide a fundamental treatment method to regenerate neuronal brain cells, and therefore, the use of stem cells for curing chronic stroke could be a major breakthrough development. In this review, we describe the features and classification of stroke and focus on the benefits of adipose tissue-derived stem cells and their applications in stroke animal models. The results show that cell-based therapies have resulted in significant improvements in neuronal behaviors and functions through different molecular mechanisms, and no safety problems have so far arisen after transplantation. Further, we propose a clinical possibility to create a homing niche by reducing the degree of invasive intracerebroventricular transplantation and combining it with continuous intravenous administration to achieve a complete cure.

Publisher

SAGE Publications

Subject

Transplantation,Cell Biology,Biomedical Engineering

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3